|
Our services
Consulting - technical support
for the anti-infective business
The Center for Anti-Infective
Agents, its principal, U. Theuretzbacher,
and its team of associated experts offer a number of services to help
pharmaceutical and biotechnology companies bring their products to market
faster. The following are just some examples of topics that we can offer:
Consulting services for pharmaceutical
companies and research institutions:
| • |
Developing R&D strategies
including product profile development, clinical trial evaluation
and development strategy, regulatory strategies.
|
| • |
Delivering of expert opinion.
|
| • |
Assisting with business development:
- Licensing evaluation support, product and technology analysis and
opportunity assessment.
- Transatlantic Liaison: introductions to thought leaders on both
sides of the Atlantic, identifying and pre-qualifying potential partners,
pre-scheduling transatlantic meetings and itineraries, representing
your company.
- Deal-making: identifying suitable products and partners, providing
a shortlist worldwide with products for in-licensing using our in-house
database and extensive international network, assessing candidates. |
| • |
Knowledge management: generating,
collecting, interpreting and communicating scientific, medical and
business information, using
in-house and external databases, scientific and business publications.
|
| • |
Developing publication strategies:
supporting the planning and writing of strategic communications of
scientific advances. Designing and exercising the publication strategy. |
| • |
Education and Training:
providing education to the staff as needed. Providing literature and
reference service to clinical teams. |
Consulting services for investors:
| • |
Providing opportunity assessment, due
diligence and valuation.
|
Consulting services for the medical community:
| • |
Assisting with developing clinical
evidence based guidelines and changing attitudes in the diagnosis
and treatment of infectious diseases.
|
| • |
Providing expert antibiotic and pharmacoeconomic
decision support.
|
|
